Key Record Dates
| ClinicalTrials.gov Identifier: | NCT04206787 |
|---|---|
| Brief Title: | The START Study Observes Afatinib as First-line Treatment and Sequential Therapy in Patients With Epidermal Growth Factor Receptor (EGFR) Mutation-positive Advanced Nonsmall Cell Lung Cancer |
| First Submitted : | December 11, 2019 |
| First Submitted that Met QC Criteria : | December 18, 2019 |
| First Posted : | December 20, 2019 |
| Last Update Submitted that Met QC Criteria : | January 11, 2021 |
| Last Update Posted : | January 12, 2021 |